STAT3 and hepatocellular carcinoma: In a study on hepatocellular carcinoma (HCC), IL-11 was shown to promote tumor cell proliferation and resistance to apoptosis by activating the STAT3 signaling pathway, contributing to cancer recurrence in postoperative HCC patients (33).